Doctoral Training Partnerships: a range of postgraduate training is funded by the Research Councils. For information on current funding routes, see the common terminology at https://www.ukri.org/apply-for-funding/how-we-fund-studentships/. Training grants may be to one organisation or to a consortia of research organisations. This portal will show the lead organisation only.

Humanity faces critical global challenges in supplying clean energy, food, medicines and materials for a population forecast to reach 10 billion by 2050. Chemical synthesis will play a central role in addressing these challenges, as organic molecules are the fundamental building blocks of drugs, agrochemicals, and materials. However, the synthesis of most chemicals remains energy intensive, requiring fossil fuel feedstocks and endangered metal catalysts, and produces huge levels of waste - far from what is needed for a net-zero future. The essential transition to a circular chemistry economy will materialise only with a total re-think of organic synthesis: a 'Chemical Revolution' is urgently needed, for which Industry users will require a 'next generation' of suitably trained graduates. Without such change, the chemical industry will not be able to sustain the necessary pace of innovation in new chemical technologies, in the face of rapidly changing chemical regulation and policy, thus rendering this CDT crucial for the future of UK PLC. The Oxford-York ESPRC CDT in Chemical Synthesis for a Healthy Planet will deliver world-leading, ground-breaking training to a next generation of synthetic chemists, developing a sustainable, innovative chemistry culture that equips them to address major emerging and future global challenges in Human Health, Energy and Materials, and Food Security. In doing so, we meet a critical User Need, by supplying the workforce that is essential to create the innovative solutions UK chemical industries urgently require. Our overarching objective is to train students to supersede current practices for the synthesis of functional organic molecules by developing sustainable, field-advancing synthetic pathways to the complex targets needed in drug discovery, agrochemistry, and materials development. Our student cohorts will work together in a training period at both Oxford and York, before engaging with industry co-supervised projects in four research fields that develop innovative, sustainable transformations and synthetic strategies, and apply them in pharma, agro and materials chemistry contexts. With around a third of projects supervised jointly at Oxford and York, we will ensure a strong cross-institute connection; whole programme meetings and research field seminars will enable students across multiple cohorts to contribute to and elevate each others' science. Our association with the Eur1.25bn Center for the Transformation of Chemistry brings a unique connection for our students to a major initiative that is aiming to revolutionise chemical synthesis, as well its >140 chemical organisations across Europe. Our partnership with >10 SMEs and their Entrepreneurs-in-Residence will develop entrepreneurial skills and ensure students are exposed to the cutting-edge of chemical innovation in UK PLC. The applications and benefits from the CSHP CDT are many: Primarily, we will develop a UK-wide network of sustainably-minded, innovative chemists ready to meet the urgent User Needs of the UK chemical industry, bolstering this major sector of UK PLC. The scientists graduating from the CSHP CDT, the high-level science they produce, along with the related tools and technologies, will all contribute to the UK's ambitions as a Physical and Mathematical Sciences Powerhouse. We will set new benchmarks for graduate training by ensuring sustainability is embedded and visible in all research and its outputs, as well as influencing and connecting to graduates across the UK through biennial symposia. Our cohorts' work as Sustainability Ambassadors will permeate our exciting discoveries and the message of the future role of synthetic chemistry throughout society - from school to the general public. Above all, we believe this rigorous and inspirational programme is utterly essential if the UK is to remain globally competitive in the rapidly evolving chemistry landscape.

Chemical Synthesis (CS) is an area upon which much of modern society relies as it enables the customized fabrication of products that are the ubiquitous materials of life and society. These include new drugs and medicines, new materials and polymers, nanomaterials, and a vast range of fine and effect chemicals on which the texture and quality of our lives depend. Without future core developments in the chemical sciences, UK plc and societal progress will stall and be left behind in a ferociously competitive modern world. We now plan to train a new generation of world-class PhD students so that the UK chemical industry can maintain its competitive position in the world as a place for highly innovative and creative research. One of the hardest aspects of CS is mastery of the vast 'synthetic tool box' of techniques required to become a professional chemist. The perfect chemist would be akin to highly skilled F1 mechanic with a state of the art toolbox and the ability to design and engineer from scratch - a molecular mechanic if you like. However in reality a student is often focussed too narrowly towards a particular area of synthesis and as a result can end up with a budget toolkit and a limited range of experience. We wish to explore CS by adopting a new 'Holistic' research approach that will be integrated with a revolutionary e-learning framework in a way that has not been previously articulated in the field of Chemistry. Instead of a traditional 'one PI - one-student - one idea' programme, we wish to bring together a group of internationally renowned chemists from organic, inorganic, physical and theoretical backgrounds to pool their skills in order to design from the ground up new and useful solutions for chemical synthesis. Our Research Opportunities Group (ROG) at Bristol does exactly this by bringing together staff from across and outside the chemistry discipline to discuss potential research areas in a Brainstorming format customized to our needs. We have found that this has been highly effective and has led to new research that simply would not have blossomed in a traditional approach. We now wish to instill our ROG philosophy and modus operandi into our students. Our aim is to get these students to think about their research as a collective rather than as isolated individuals working in separate research groups. The benefits of this will be enormous, not least in that they will all play an active role in the design of each-others projects as well as being exposed to a pool of supervisory experience of great breadth and experience. Key to the training experience will be the design and implementation of a revolutionary e-learning resource called the postgraduate Dynamic Laboratory Manual (pgDLM). The pgDLM will allow students to carry out a virtual version of an essential, often complex, experimental technique before experiencing it in the laboratory thus gaining a much deeper understanding of an experiment before they carry it out for real . By creating a pgDLM with an evolving library of online techniques we will not only enable students to embrace new techniques confidently but also simultaneously establish a valuable resource which will be made available to all practitioners of CS in both academe and industry. Industry will play a key role in defining the focus and contemporary relevance of the csDTC and will be broadly represented on a Steering Group. These external advisors will play an active role in project selection, assessment and will participate in the training programme. By producing the right product and working closely with industrial partners from the outset, the csDTC will be well positioned to leverage external support to sustain the Centre beyond the EPSRC funding period. Through this vision we aim to produce a new generation of industrial and academic leaders and, by delivering this goal, secure Bristol as a premier centre for Chemical Synthesis.

Synthesis, the science of making molecules, is central to human wellbeing through its ability to produce new molecules for use as medicines and materials. Every new drug, whether an antibiotic or a cancer treatment, is based on a molecular structure designed and built using the techniques of synthesis. Synthesis is a complex activity, in which bonds between atoms are formed in a carefully choreographed way, and training to a doctoral level is needed to produce scientists with this expertise. Irrespective of the ingenuity of the synthetic chemist, the complexity of synthetic endeavours means that they are often the pinch point in the development of a new product or the advance of new molecular science. In addition, synthesis can no longer rely on intensive use of human, material, and time resources, and creative solutions to ways of making molecules faster, more efficiently, using less energy, and avoiding rare to toxic metals are urgently needed. Recent developments in digital chemistry (eg reaction technology and automation, data collection & analysis, machine learning & artificial intelligence, computation & molecular design, and the use of virtual reality) now make possible a fundamental change in the way molecular targets are identified and synthesis is carried out. The chemical and pharmaceutical discoveries which underpin a major sector of the UK's economy are almost entirely dependent on synthesis, and our industrial partners see an urgent need for a new generation of employees who combine cutting-edge chemical synthesis expertise with the state-of-the-art digital skills that are set to revolutionise the field. We therefore propose a CDT that will train students to carry out world-leading chemical synthesis at the University of Bristol, the UK's top institution for chemistry research (REF2021), with their creativity and productivity being enhanced by an initial 8-month Digital Chemistry (DC) training focus that un-derpins a subsequent 3 1/4 year PhD project. The training will be delivered in the form of a set of modules that embody key aspects of DC such automation, algorithm-driven optimisation, photochemistry, electrochemistry and flow chemistry supported by training in the techniques of machine learning and data analysis. These activities will be applied to current synthetic challenges in two short immersive 'mini-projects' in research labs and will feed into a PhD research project in an area of synthetic chemistry that is underpinned by the application of digital chemistry methods. The focus of the CDT aligns with Bristol's global reputation in chemical synthesis and computation, and in its current investment in digital chemistry as a strategic research direction. Bristol Chemistry has enviable success in spinout companies, and alongside ongoing training in professional development skills we aim to cultivate an entrepreneurial ethos by partnering with local start-up partners to provide immersive workshops, placements, network links and mentorship to nurture future spin-outs by CDT students. We will build on lessons learnt from delivering previous successful CDTs in Chemical Synthesis, and we will continue to develop our recruitment, training & research opportunities in line with best practice for Equity, Diversity & Inclusion, applying more widely lessons from the evolution that has allowed the diversity of our applicant team to be reflected in the ~50/50 M:F and ~25% minority ethnic composition of our management committee. Our evolved CDT will build on our unrivalled depth of experience to train diverse cohorts of creative and entrepreneurial experts in chemical synthesis, skilled in modern aspects of technology & data science. Our graduates will be uniquely prepared as research pioneers in the ever-changing scientific and industrial landscape of the chemical sciences that continue to underpin this country's prosperity.

Lung diseases such as Asthma and Chronic Obstructive Pulmonary Disease affect one in five people in the UK and kill someone every 5 minutes. The number of patients with these lung diseases was increasing in the NHS even before COVID-19. We are also learning about serious long-term effects of COVID-19 that will add to the existing burden on the NHS. There have been huge advances in technologies that allow scientists to see inside the lungs and measure what we breathe out. While this information has taught us quite a lot, it is still very difficult to combine different sources of information and turn it into new or improved treatments. Getting that useful information out of large amounts of medical test results requires sophisticated physics-based mathematical and statistical models run on powerful computers - a combination of techniques called data-driven biophysical multiscale modelling. The ability to develop those kinds of models will allow us to better understand how diseases start and how they progress. Our BIOREME network will support new research that uses these techniques to mimic biological and mechanical processes that occur throughout the lung. Using the information from thousands of lung tests, the idea is then to get these models to mimic real diseased lungs. In order to improve and build trust in these models, some of our projects will be focused on comparing their outputs to results from other lung tests. Medical scientists can then use such models to test what might happen in a particular type of lung disease, and to investigate possible responses to new treatments before testing these in patients. Most importantly, this will lead to the design of new drugs and improved trials for new treatments. The first step will be to get medics, imaging experts and mathematicians together with industry and patient group representatives to decide on which specific research areas to prioritise, where this form of modelling will make the most difference. This NetworkPlus award will then allow us to organise multiple events, in different formats, designed to help researchers to collaborate, and to come up with the best initial projects to help achieve our goals. We will then help the researchers to develop these into larger projects that will attract funding from other sources and continue the research into the future. Even after this funding runs out, BIOREME will provide a lively forum for lung researchers to continue solving problems using these advanced computational tools. Finally, BIOREME will support outreach activities to engage and educate communities and young people in the role that mathematics can play in medicine and healthcare, and to inspire a new generation of respiratory scientists from diverse backgrounds.